Clinical Trials Browser

Phase 2 × Melanoma × B-Cell Activating Factor × Clear all

NCT00006113 2014-05-22

Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma

Phase 2 Terminated

Melanoma